U.S. searches for new AstraZeneca vaccine producer after Emergent mix-up
U.S. health officials are helping AstraZeneca find a new manufacturing partner for millions of its coronavirus shots after the contractor Emergent BioSolutions mixed up ingredients for two Covid-19 vaccines it’s simultaneously producing, a senior health official told POLITICO.
The Biden administration already told Johnson & Johnson to directly take over vaccine manufacturing at Emergent’s Maryland plant after reports that the manufacturer had contaminated 15 million Johnson & Johnson doses with ingredients for AstraZeneca’s shot.
But now, officials are telling AstraZeneca to cut ties with Emergent entirely, worried about the prospect for more mishaps that could erode public confidence in Covid vaccines, the official said. They added that the administration has identified two potential partners for AstraZeneca to work with on future production.